Effect of denosumab on bone turnover markers in postmenopausal osteoporosis: Initial response and subsequent release from suppression

被引：0
|
作者：
Eastell, R. [1 ]
Austin, M. [2 ]
Martin, J. San [3 ]
McClung, M. R. [4 ]
Christiansen, C. [5 ]
Libanati, C. [3 ]
Siris, E. S. [6 ]
Cummings, S. R. [7 ]
机构：
[1] Univ Sheffield, Acad Unit Bone Metab, Sheffield, S Yorkshire, England
[2] Amgen Inc, Clin Biostat, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Dept Med, Thousand Oaks, CA 91320 USA
[4] Univ Oregon, Oregon Osteoporosis Ctr, Portland, OR USA
[5] Ctr Clin & Basic Res, Dept Med, Ballerup, Denmark
[6] Columbia Univ, Med Ctr, Dept Med, New York, NY USA
[7] UCSF, Clin Trial Coordinating Ctr, San Francisco, CA USA
来源：
BONE | 2009年 / 44卷 / 02期
关键词：
D O I：
10.1016/j.bone.2009.03.105
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S242 / S243
页数：2
相关论文
共 50 条
  • [31] Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
    K. E. Naylor
    R. M. Jacques
    M. Paggiosi
    F. Gossiel
    N. F. A. Peel
    E. V. McCloskey
    J. S. Walsh
    R. Eastell
    Osteoporosis International, 2016, 27 : 21 - 31
  • [32] Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
    Naylor, K. E.
    Jacques, R. M.
    Paggiosi, M.
    Gossiel, F.
    Peel, N. F. A.
    McCloskey, E. V.
    Walsh, J. S.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 21 - 31
  • [33] PROPHYLACTIC TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - EFFECT ON BONE TURNOVER
    THOMSEN, K
    ACTA ORTHOPAEDICA SCANDINAVICA, 1987, 58 (06): : 708 - 708
  • [34] BONE TURNOVER IN POSTMENOPAUSAL OSTEOPOROSIS - EFFECT OF CALCITONIN TREATMENT
    CIVITELLI, R
    GONNELLI, S
    ZACCHEI, F
    BIGAZZI, S
    VATTIMO, A
    AVIOLI, LV
    GENNARI, C
    JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04): : 1268 - 1274
  • [35] The Relationship Between the FRAX Tool and Bone Turnover Markers in Postmenopausal Osteoporosis
    Uludag, Murat
    Akarirmak, Ulku
    Ozbayrak, Sibel
    Bolayirli, Murat
    Tuzun, Sansin
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2013, 19 (02): : 38 - 41
  • [36] THE RELATIONSHIP BETWEEN THE FRAX TOOL AND BONE TURNOVER MARKERS IN POSTMENOPAUSAL OSTEOPOROSIS
    Uludag, M.
    Akarirmak, U.
    Ozbayrak, S.
    Bolayirli, M.
    Tuzun, S.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : 689 - 690
  • [37] Comparison of the effects of denosumab with either active vitamin D or native vitamin D on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Suzuki, Takako
    Nakamura, Yukio
    Tanaka, Mizue
    Kamimura, Mikio
    Ikegami, Shota
    Uchiyama, Shigeharu
    Kato, Hiroyuki
    MODERN RHEUMATOLOGY, 2018, 28 (02) : 376 - 379
  • [38] Effect of Strontium Ranelate on Serum Leptin and Bone Turnover Markers in Women with Established Postmenopausal Osteoporosis
    Bayhan, Ilhan
    Dogan, Nasuh U.
    Ozaksit, Gulnur
    Uygur, Dilek
    Ugurlu, Nil
    Ugur, Mustafa
    JOURNAL OF REPRODUCTIVE MEDICINE, 2013, 58 (7-8) : 319 - 323
  • [39] The response to alendronate in postmenopausal osteoporosis depends on bone turnover.
    Gennari, C
    Gonnelli, S
    Cepollaro, C
    Pondrelli, C
    Montagnani, A
    Rossi, B
    Monaco, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F471 - F471
  • [40] Bone turnover markers in postmenopausal osteoporosis and their correlation with bone mineral density and menopause duration
    Gurban, Camelia Vidita
    Balas, Melania Olga
    Vlad, Mihaela Maria
    Caraba, Alexandru Emil
    Jianu, Adelina Maria
    Bernad, Elena Silvia
    Borza, Claudia
    Banicioiu-Covei, Simona
    Motoc, Andrei Gheorghe Marius
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2019, 60 (04): : 1127 - 1135
12345